Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Abattis Bioceuticals Corp ATTBF

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.


GREY:ATTBF - Post by User

Bullboard Posts
Comment by Irontankon Aug 15, 2017 7:17pm
133 Views
Post# 26585407

RE:Just Wait For It.

RE:Just Wait For It.I guess I just answered my own question - once Experion receives their the letter from Health Canada authorizing them to produce under Canada's ACMPR - Also - again the update on the fact that the build in Mission is now complete - Not surprised because they mentioned in a previous NR that they were fast tracking the build out.

Experion has now completed construction of its indoor marijuana production, secure storage and processing facility located near Mission, B.C. Under new Health Canada guidelines, which became effective in late May, 2017,


Upon closing of the offer, the offer will result in a reverse takeover of Morro Bay by Experion. The offer is subject to the acceptance of the exchange to list the shares of the resulting entity on the exchange. Additional conditions must be met in order for the offer to be completed. It is anticipated the final closing and listing of the resulting issuer shares on the TSX Venture Exchange will not occur until Experion has obtained its licence to produce medical cannabis products pursuant to the access to cannabis for medical purposes regulations (ACMPR).

As previously described in Morro Bay's June 7, 2017, news release, Experion has received a confirmation of readiness letter from Health Canada in regard to the Experion ACMPR licence application. Experion has now completed construction of its indoor marijuana production, secure storage and processing facility located near Mission, B.C. Under new Health Canada guidelines, which became effective in late May, 2017, the facility is not required to undergo a prelicence inspection in advance of issuance of the licence to produce; however, Experion was required to provide evidence of the facility's readiness to commence production. Upon completion by Health Canada of its review of documentation submitted by Experion (demonstrating its readiness to commence production) and completion of any remedial work required by Health Canada, Experion anticipates receiving its ACMPR licence.

Bullboard Posts